Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP ‐ 1R activation

Abstract excerpt

The incidence of type 2 diabetes in developed countries is increasing yearly with a significant negative impact on patient quality of life and an enormous burden on the healthcare system. Current biguanide and thiazolidinedione treatments for type 2 diabetes have a number of clinical limitations, the most serious long-term limitation being the eventual need for insulin replacement therapy (Table 1). Since 2007,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes Treatment and Management
• Share to Pancreatic function and diabetes
• Share to Receptor Mechanisms and Signaling